CC
BIIB icon

Corton Capital’s Biogen BIIB Stock Holding History

Corton Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,978
Closed -$512K – 517
2023
Q4 		$512K Buy
1,978
+711
+56% +$175K 0.16% 161
2023
Q3 		$326K Buy
+1,267
New +$339K 0.16% 178
2022
Q4 		– Sell
-1,247
Closed -$333K – 309
2022
Q3 		$333K Sell
1,247
-353
-22% -$75K 0.41% 87
2022
Q2 		$326K Sell
1,600
-1,420
-47% -$290K 0.31% 126
2022
Q1 		$636K Buy
+3,020
New +$657K 0.28% 71

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Corton Capital's BIIB Position: Q1 2024 in Review

Corton Capital sold out of Biogen (BIIB) in Q1 2024, closing a stake of 1,978 shares — an estimated $512K sold.

Corton Capital first reported a position in BIIB in Q1 2022 and held it in 5 quarters. The position peaked at $636K in Q1 2022. 954 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • Corton Capital reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
  • Corton Capital sold 1,978 Biogen shares in Q1 2024, an estimated $512K.
  • Corton Capital first reported a position in Biogen in Q1 2022 and held it in 5 quarters.
  • Corton Capital's Biogen position peaked at $636K in Q1 2022.
  • 954 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Corton Capital's 13F filing for Q1 2024, filed 15 May 2024.